Journal Home
Search for

Volume 228, Issue 1, Pages 59-63 (18 October 2005)


View previous. 12 of 43 View next.

Phox2B mutations and the Delta–Notch pathway in neuroblastoma

Vera van Limpta, Alvin Chana, Alexander Schrammb, Angelika Eggertb, Rogier VersteegaCorresponding Author Informationemail address

Received 3 January 2005; accepted 5 February 2005.

Abstract 

We recently identified six neuroblastoma patients with constitutional or tumor-specific mutations in the homeobox gene Phox2B. Phox2B controls part of the differentiation program of the sympathetic nervous system (SNS). Mice with a homozygous inactivation of Phox2B fail in the proper differentiation of the chromaffin lineage of the SNS. Phox2B regulates HASH1 which can control expression of genes of the Delta–Notch pathway. We previously showed that a subset of neuroblastoma cell lines highly expresses Delta-like 1 (Dlk1), which is a marker for the chromaffin lineage of the SNS. Notch3 is expressed in another subset of neuroblastoma cell lines and marks tumors from an alternative differentiation lineage. Phox2B is also related to the TrkA differentiation pathway in neuroblastoma. Here we will review the role of Phox2B in differentiation programs of the SNS and in neuroblastoma pathogenesis.

a Department of Human Genetics, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands

b Department of Oncology/Hematology and Endocrinology, University Children's Hospital Essen, Hufelandstrs. 55, 45122 Essen, Germany

Corresponding Author InformationCorresponding author. Tel.: +31 10 463 6691/2073; fax: +31 10 463 6801.

PII: S0304-3835(05)00361-7

doi:10.1016/j.canlet.2005.02.050


View previous. 12 of 43 View next.